Growth Metrics

Cumberland Pharmaceuticals (CPIX) Change in Accured Expenses (2016 - 2026)

Cumberland Pharmaceuticals' Change in Accured Expenses history spans 16 years, with the latest figure at $8.0 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 2580.43% to $8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.7 million, a 776.77% increase, with the full-year FY2025 number at $6.7 million, up 776.77% from a year prior.
  • Change in Accured Expenses hit $8.0 million in Q4 2025 for Cumberland Pharmaceuticals, up from $684224.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CPIX hit a ceiling of $8.0 million in Q4 2025 and a floor of -$3.3 million in Q4 2023.
  • Historically, Change in Accured Expenses has averaged $904548.0 across 5 years, with a median of $166060.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: surged 2957.92% in 2022 and later crashed 185.82% in 2024.
  • Tracing CPIX's Change in Accured Expenses over 5 years: stood at $2.1 million in 2021, then soared by 172.09% to $5.8 million in 2022, then crashed by 157.46% to -$3.3 million in 2023, then soared by 90.2% to -$324294.0 in 2024, then surged by 2580.43% to $8.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CPIX at $8.0 million in Q4 2025, $684224.0 in Q3 2025, and -$1.4 million in Q2 2025.